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Abstract
Background: Base-resolution methylome data generated by whole-genome bisulfite sequencing (WGBS) is often
used to segment the genome into domains with distinct methylation levels. However, most segmentation
methods include many parameters to be carefully tuned and/or fail to exploit the unsurpassed resolution of the
data. Furthermore, there is no simple method that displays the composition of the domains to grasp global
trends in each methylome.
Results: We propose to use changepoint detection for domain demarcation based on base-resolution methylome
data. While the proposed method segments the methylome in a largely comparable manner to conventional
approaches, it has only a single parameter to be tuned. Furthermore, it fully exploits the base-resolution of the
data to enable simultaneous detection of methylation changes in even contrasting size ranges, such as focal
hypermethylation and global hypomethylation in cancer methylomes. We also propose a simple plot termed
methylated domain landscape (MDL) that globally displays the size, the methylation level and the number of the
domains thus defined, thereby enabling one to intuitively grasp trends in each methylome. Since the pattern of
MDL often reflects cell lineages and is largely unaffected by data size, it can serve as a novel signature of
methylome.
Conclusions: Changepoint detection in base-resolution methylome data followed by MDL plotting provides a
novel method for methylome characterization and will facilitate global comparison among various WGBS data
differing in size and even species origin.
Background
Cytosine methylated at its C5 position or 5-methylcytosine
(5mC) in genomic DNA plays pivotal roles in a wide var-
iety of biological processes. In mammalian cells, 5mC
residues principally occur in the context of 5′-CG-3′ dinu-
cleotides or CpG sites, and those at promoters are gener-
ally regarded as an important epigenetic mark that leads to
gene silencing. Since some transcription factors fail to
recognize the methylated versions of their cognate binding
sequences, it is formally possible that the cell uses DNA
methylation in a sharply focused manner by targeting at a
particular CpG site to regulate gene expression. However,
most 5mC residues seem to be controlled not independ-
ently but more or less coordinately with their neighbours,
leading to generate a domain wherein all CpG sites show a
largely similar methylation level.
Recent advent of next-generation sequencing tech-
nologies has enabled whole-genome bisulfite sequencing
(WGBS) to provide highly quantitative methylation data
for every cytosine residue in the genome [1, 2]. The
base-resolution methylome data is used to segment the
methylome into domains with distinct methylation
levels. It had been thought that vertebrate genomes are
globally methylated to a high level but punctuated with
small unmethylated regions, which often include pro-
moters, enhancers, CpG islands and so on [3]. WGBS
has not only confirmed this notion but led to finer
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definitions of methylated domains, revealing those that
may be characteristic to developmental stages, tissues or
disease states. For instance, the first human WGBS
revealed partially methylated domains (PMDs) in fibro-
blast IMR90 but not in embryonic stem cell (ESC) H1
[4]. On the other hand, a WGBS study on mouse ESC
led to propose unmethylated regions (UMRs), low-
methylated regions (LMRs) and fully methylated regions
(FMRs) [5], whereas another one on four ESC-derived
cell types, which reflect early developmental lineages,
led to a proposal of a domain termed DNA methylation
valley (DMV) [6].
While such methylated domains are often intuitively
obvious upon genome browsing, their boundaries should
be rationally defined. However, the methods used thus
far require substantial optimization steps and have vari-
ous limitations in domain identification. For instance,
the study that proposed PMDs used a sliding window-
based approach [4]. While this approach is simple and
easy, it cannot detect domains smaller than the pre-
defined window size, which is often determined in a
rather ad hoc manner, depending on the purpose of
investigations. Furthermore, window-based approaches
use only the mean methylation level of CpG sites in
each window, thereby failing to fully exploit the base-
resolution of WGBS data. The study that proposed
UMRs, LMRs and HMRs used hidden Markov model
(HMM) to classify individual CpG sites into three DMA
methylation states [5]. While the call of HMM is per-
formed at base-resolution, one has to determine the
number of methylation states beforehand and the cri-
teria to define domains based on the states of individual
CpG sites.
As an alternative approach to define methylated do-
mains, we tested the feasibility of using changepoint
detection. Detecting points of change in a serial meas-
urement data is a general problem that is important not
only for natural sciences (e.g., climatology, oceanog-
raphy, etc.) but also in many other areas including the
analysis of network traffic and finance [7]. Estimating
points of change from statistical properties of measure-
ment data is termed as changepoint detection. In the
field of genomics, it has been successfully applied to
detect chromosomal copy number variations from array
comparative genomic hybridization data [8, 9] and, more
recently, from next-generation sequencing data [10], prov-
ing its excellent performance [11].
While changepoint detection has demonstrated its
power in various areas, it suffers from enormous com-
putational burden. It basically uses a cost function C to
compare the sum of cost between before and after each
domain separation. When examining the changes in
mean value of measurement, the cost function is de-
fined as:




where k and n are the start and end points of a domain,
respectively, and Xi is a measured value at point i,
whereas μ is the mean value of measurements in the do-
main. To place a changepoint t in a measurement of size
N, one should satisfy the following formula:
C 1 : Nð Þ > C 1 : tð Þ þ C t þ 1 : Nð Þ þ β ðð2ÞÞ
where β is the penalty value to prevent over-
segmentation. The optimal changepoint is identified as
the t that can minimize the value of the right side of
formula (2). Since the computational cost to identify a
changepoint t that separates a measurement into two do-
mains increases linearly with the size of measurement N,
the calculation is O(N). Although dynamic programing
can consider all possible combinations between segments
to detect multiple changepoints [12, 13], the calculation
has a computational cost of O(N3), which makes its appli-
cation to large data including WGBS prohibitive. How-
ever, a recently proposed algorithm termed Pruned Exact
Linear Time (PELT) has enabled efficient calculation to
detect multiple changepoints in almost linear computa-
tional time [14].
In this study, we applied the multiple changepoint de-
tection procedure of PELT to base-resolution methylome
data generated by WGBS to determine the boundaries of
methylated domains or domains with distinct methyla-
tion levels. We also devised a novel plot termed methyl-
ated domain landscape (MDL) to grasp the global
composition of the domains thus defined and found that
the pattern of the plot can serve as a signature of each
methylome.
Results
Changepoint detection in base-resolution methylome
data
To test whether changepoint detection can define the
boundaries of a domain with a distinct methylation level
from base-resolution methylome data, we used the
WGBS data of human ESC H1 and human lung fibro-
blast IMR90 [4]. While the ESC methylome includes a
substantial number of methylated non-CpG sites, this
study focuses on CpG sites, the major targets of mam-
malian DNA methylation. Since CpG sites do not appear
in the genome with a constant interval, we first intended
to take the distance between adjacent CpG sites into ac-
count to define the domains. However, we could not ra-
tionally select any objective model for the purpose. We
thus dared to ignore the distance and regarded the CpG
methylation data as a simple successive series of meas-
urement data (Fig. 1a). We used the PELT procedure
through the R package “changepoint” [14] without any
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modification to identify boundaries. Following the calcu-
lation, we assigned original genomic coordinates to the
identified changepoints and displayed each domain by a
horizontal line that connects the adjoining changepoints,
the vertical level of which indicates the mean methyla-
tion level. Judged from their appearance, the domains
thus defined were mostly reasonable and of acceptable
quality (Fig. 1b). As shown in Fig. 1b, several domains
showed different methylation status between the two cell
types and were largely coincident with the differentially
methylated regions (DMRs) defined by a window-based
approach [4]. Since even naïve application of change-
point detection was found to be useful for the analysis of
DNA methylation patterns, we decided to pursue this
approach more practically by preparing a PELT imple-
mentation of our own that was optimized for efficient
calculation of genome-scale data in a parallel computa-
tional environment.
Penalty value to control sensitivity in domain
demarcation
To prevent over-segmentation, changepoint detection
uses a penalty value for placement of boundaries (see
formula (2)). The original implementation of PELT in
“changepoint” package [14] makes the penalty value
dependent on the size of data to normalize information
content. We, however, used a fixed penalty value inde-
pendently of data size, since the sensitivity of change-
point detection should not differ from one chromosome
to another. As expected, the higher the penalty value
was, the smaller the number of the detected domains
was (Fig. 2a and b). For instance, many small domains of
low methylation levels were missed, unless low penalty
values were used (Fig. 2b, arrowheads). These domains
seem to include such regions around promoters that
escape methylation. While detection of such domains is
important, too low penalty values result in detection of
very tiny domains, most of which contain only a single
CpG site (Fig. 2a). Through careful evaluation of the
effects of penalty values from a practical point of view, we
empirically decided to use a single penalty value of 1.0
throughout this study unless otherwise noted, because it
seemed to give, in most cases, a good balance between
sensitivity and specificity in domain detection. Note that
changepoint detection requests its users to tune only a
single parameter, in contrast with window-based ap-
proaches, which have, at least, three parameters (i.e.,
window size, step size and the criteria to merge neigh-
bouring windows) to be optimized depending on the
purpose of analysis.
We also assume that the inverse relationship between
penalty value and detection sensitivity can serve as a
measure of reliability for each boundary. Iterative calcu-
lation of boundaries under various penalty values can
identify the maximum penalty value above which each
boundary cannot be detected anymore. The plot of the
maximum penalty value for each boundary would be
helpful to interpret domain demarcation (Fig. 2b).
Visualization and evaluation of changepoint
detection-defined domains
While genome browser enables local visualization of do-
main demarcation status, it cannot show global trends
in methylome segmentation or the composition of do-
mains (i.e., number, size and methylation level of
domains). For this purpose, we plotted the size and the
mean methylation level of each domain on horizontal
and vertical axes, respectively, and used pseudocolor
encoding to indicate relative density of the domains.
We termed this simple plot as methylated domain
landscape (MDL). Examples of MDL were shown for vari-
ous publicly available WGBS data (Fig. 3 and Additional
files 1 and 2). Intriguingly, the domains are not evenly
Fig. 1 Changepoint detection in base-resolution methylome data. a A scheme for application of changepoint detection to base-resolution
methylome data. b Comparison of methylome data for human ESC H1 and fibroblast IMR90 by Lister et al. [4]. A genomic region containing
promoters for COMMD7 and DNMT3B genes (chr20, 31,327,500–31,362,500) is shown. Gray dots indicate methylation levels of individual CpG
sites that are covered by at least ten reads. Red horizontal bars indicate methylated domains defined by changepoint detection. The vertical
level of each bar indicates the mean methylation level of each domain. Blue bars indicate DMRs detected by Lister et al. [4] and by changepoint
detection
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distributed on the plane but rather confined to limited
areas. MDL plots generally take a shape that looks like the
head and neck of a bird and contains three major clusters
of domains. The first cluster is composed of highly meth-
ylated domains whose sizes range from 1 kb to several Mb
(cluster #1 in Fig. 3a). The second cluster, which is often
less prominent than the other two, is composed of short
domains ranging from 100 bp to 1.5 kb with low-to-
moderate methylation levels (cluster #2 in Fig. 3a). The
third cluster is composed of unmethylated domains ran-
ging from 1 kb to 3 kb (cluster #3 in Fig. 3a).
It is intriguing to note that a previous study applied an
HMM approach to a mouse ESC data to define three
classes of regions termed FMRs, LMRs and UMRs [5].
To test whether these classes correspond to the three
clusters observed in MDL plot, we applied the change-
point detection to the same mouse ESC data, extracted
such domains that overlap with the FMRs, LMRs or
UMRs, and displayed each of them as a separate plot
(Fig. 3b and Additional file 3). The changepoint detection-
defined domains did not completely coincide with the
HMM-defined regions (Fig. 3c). However, the domains
overlapping with each class were clearly separated on
MDL plot and largely coincident with the three clusters
(Fig. 3b and Additional file 3). We also used MethySeekR
[15] derived from the HMM-based approach [5] to con-
firm the overlap between the clusters and the classes
(Additional file 3). These results would serve as a proof of
concept for the changepoint detection approach. Con-
versely, we applied MDL plot to the result of HMM
approach [5] and observed a pattern largely similar to
that by changepoint detection. Curiously, however, the
MDL plot of HMM-mediated segmentation revealed an
unnatural gap indicating the apparent absence of domains
methylated at the level of ~50 % for unknown reason
(Additional file 3).
While most MDL plots shared the bird’s head and
neck-like shape, some showed substantial variations. For
instance, MDL plots were distinct between ESC H1 and
fibroblast IMR90 (Fig. 3d), because the latter, but not
the former, have many large genomic regions with mod-
erate methylation levels termed PMDs in a previous
study [4]. This study defined PMDs as any region that is
larger than 10 kb and shows a mean methylation level
below 70 %. It was obvious from the MDL plots that
IMR90, but not H1, has many domains that fulfil the cri-
teria described above (Fig. 3d and Additional file 4). In-
deed, 79 % of the genomic regions in these changepoint
detection-defined PMD-like domains overlapped with
75 % of those in the PMDs defined in the original study
(Additional file 4). These results indicate that the chan-
gepoint detection approach was largely comparable to
the window-based approach in terms of detecting PMDs.
On the other hand, the MDL plots readily revealed that
the IMR90 methylome has many methylated domains
that fall short of fulfilling the original PMD criteria but
seem not to be rationally separable from PMDs (Fig. 3d).
The presence of such PMD-like domains was also obvi-
ous in placenta in both human [16] and mouse [17], hu-
man mammary epithelial cells and a breast cancer cell
line [18] (Additional files 1 and 2). These results may
argue a need for redefinition of PMDs.
In this context, it should be noted that the PMD-like
domains defined by changepoint detection under a
Fig. 2 Effects of penalty value on domain demarcation. a Effects of penalty value on domain length distribution. CpG sites covered by at least ten
reads were used for calculation. b Domain demarcation patterns are shown for a genomic region around FOXD2 gene (chr1, 47,880,913–47,915,913)
under five different penalty values. Arrowheads indicate small domains that were missed unless low penalty value were used. The bottom track
indicates the maximum penalty value above which each changepoint cannot be detected
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penalty value of 1.0 were generally smaller than the
original PMDs defined by a window-based approach: a
single large PMD by the original definition was often
regarded as a cluster of many smaller PMDs by change-
point detection (Additional file 4). This is because the
latter approach was much more sensitive to the presence
of tiny unmethylated regions than the former approach.
Indeed, changepoint detection under an extreme penalty
value ignored such regions, thereby making the domain
sizes comparable to those of original PMDs (Additional
file 4). Intriguingly, MDL plots suggested that change-
point detection can invariably detect a sizable fraction of
UMRs, but not LMRs, even under such conditions
(Additional file 4). This trend is likely attributable to the
contrasting CpG density between UMRs and LMRs [5].
Demarcation of UMRs, which are enriched for CpG’s
[5], has significant impacts on the cost function C and
hence is often allowed even under high penalty values.
By contrast, demarcation of LMRs, which are notably
CpG-poor [5], has only a limited contribution to the
improvement of the cost function C and hence is barely
allowed under a high penalty value.
We also analysed the WGBS data for mesendoderm,
neural progenitor cells, trophoblast-like cells and mesen-
chymal stem cells, all of which were differentiated from
human ESC H1 [6]. These datasets led to the proposal
DMV, which was defined as any genomic region larger
than 5 kb with a mean methylation level below 15 % [6].
Fig. 3 MDL plots for methylated domain composition. a MDL plot for mouse ESC [5]. CpG sites covered by at least five reads were used for
calculation. Clusters #1 – #3 indicate three major clusters of domains observed in most MDL plots. b Distribution of UMRs, LMRs and FMRs on
MDL plot. If more than 80 % of a changepoint detection-defined domain overlaps with previously defined UMRs, LMRs or FMRs [5], the domain
was selected and displayed in the plots labelled as UMR, LMR or FMR, respectively. c Comparison of changepoint detection-defined domains with
UMRs, LMRs and FMRs in a genomic region around Tbx3 gene (chr5, 120,100,000–120,500,000). d MDL plots for human ESC H1 and fibroblast
IMR90 [4]. Yellow dotted lines demarcate the area that fulfils the criteria used to define PMDs in the original study [4]. e MDL plots for human
mammary epithelial cells and a low-passage breast cancer cell line [18]
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MDL plots indicated the presence of domains that fulfil
the criteria (Additional file 5). Consistent with the ori-
ginal study [5], these domains were minorities but found
in all of the four cell types. Intriguingly, 66–90 % of the
genomic regions in these apparently DMV-like domains
overlapped with those in the DMVs defined in the ori-
ginal study (Additional file 5). On the other hand, the
former regions failed to cover 38–58 % of the latter re-
gions (Additional file 5). This is because changepoint
detection under a penalty value of 1.0 often divided a sin-
gle DMV defined in the original study into two or more
UMR-like domains. As the original DMVs were defined
using a sliding window-based approach with a step size
of 1,000 bp [6], their boundaries were inevitably blurred
and their sizes were likely exaggerated. Notably, the sub-
boundary portions of each DMV defined by the original
study often showed higher methylation levels than its
central portion (Additional file 5). Changepoint detection
sensitively recognized such portions as distinct domains
to provide intuitively more natural boundaries (Add-
itional file 5). Consequently, changepoint detection-
defined DMV-like domains were, in most cases, smaller
than original DMVs: some of the former failed to cover
substantial portions of the latter, others were not recog-
nized as DMV-like domains anymore because they were
smaller than 5 kb (Additional file 5).
It is well known that carcinogenesis often associates
two contrasting changes in the methylome, namely glo-
bal hypomethylation and focal hypermethylation, which
have been implicated in chromosome instability and epi-
genetic suppression of tumor suppressor genes, respect-
ively. We analysed the WGBS data of cultured primary
human mammary epithelial cells and a low-passage breast
cancer cell line [18]. Comparison between the MDL plots
of these cells indicated the emergence of large hypome-
thylation domains and small hypermethylated domains
upon carcinogenesis (Fig. 3e). It should be noted that
simultaneous detection of changes in contrasting size
ranges is demanding for conventional approaches using a
single pre-defined window size, whereas it is readily
achievable for the changepoint detection approach.
Taken together, changepoint detection can well demar-
cate the domains in a largely comparable manner with
conventional approaches, and the MDL plot is useful for
global visualization of the domains thus defined to reveal
the global trends in each methylome.
MDL plot as a signature of methylome
The observations described above prompted us to pur-
sue a possible use of MDL plot as a unique signature of
each methylome. Besides the presence of PMDs, there
are substantial variations in MDL plots. For instance,
ESC and ESC-derived lineages have less domains than
hematopoietic cells (Additional file 6). Among the ESC-
derived cell lineages [6], mesendoderm, neural progeni-
tor cells and trophoblast-like cells showed a flat head
with a sharp beak, whereas mesenchymal stem cells have
a rather round head with a dull beak (Additional file 5).
The former and the latter would thus have low and high
variance in methylation levels of the highly methylated
domains (i.e., cluster #1 or FMRs), respectively. Cells of
hematopoietic lineage often have a round head with a dull
beak, similarly to mesenchymal stem cells (Additional file
1) [19]. Intriguingly, disruption of Dnmt3a gene signifi-
cantly affected the pattern in hematopoietic stem cells
(Additional file 1) [20].
To objectively evaluate such apparent similarity, we di-
vided each MDL plot into 400 (= 20 × 20) pixels, used
the number of domains in each pixel to calculate the
Spearman’s rank-order correlation coefficient and per-
formed Ward’s clustering of various methylomes (Fig. 4a
and Additional file 6). As expected, the methylomes with
PMDs including IMR90, placenta, mammary epithelial
cells and a breast cancer cell line were clustered to-
gether. Intriguingly, the methylomes of ESC and ESC-
derived lineages formed a single cluster, and those of
hematopoietic lineages formed another cluster. These
results suggested that the extent of methylome segmen-
tation can be unique to cell lineage and hence serve as a
novel signature of each methylome. The result of MDL-
based clustering was largely consistent with those of con-
ventional clustering based on the methylation levels of ei-
ther individual CpG sites or sliding windows (Additional
file 6). However, the latter approach placed mesenchymal
stem cells in the cluster of PMD-positive cells (Additional
file 6). MDL-based clustering can be thus more sensitive,
at least, to some types of change than conventional clus-
tering, thereby serving as a novel approach complemen-
tary to conventional ones in methylome data analysis.
We next intended to examine the robustness of MDL
plot against data size, because the number of reads differ
substantially among various WGBS data. In principle,
the deeper one sequences the methylome, the more ac-
curately one can estimate methylation levels. Accord-
ingly, a threshold for read depth is usually set to select
CpG residues used for the calculation of methylation
levels, while discarding the others from subsequent ana-
lysis. In other words, shallow sequencing depth tends to
lose both accuracy and coverage. We thus examined the
effects of read depth on domain demarcation by change-
point detection. For this purpose, we used the WGBS
data for IMR90 [4], because it covers the human genome
by more than 40-fold, when combining the two bio-
logical replicate data. We prepared ten IMR90 datasets
whose sizes were 10–100 % of that of the full data, and
used each of them to calculate domain boundaries under
three different threshold values (i.e., minimal read
depths) to calculate methylation levels. As expected, the
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number of domains and the genomic coverage were
dependent on the amount of reads used for the calcula-
tion (Fig. 4b and c). Higher thresholds requested more
reads to detect the same number of domains or to
achieve the same genomic coverage (Fig. 4b and c). Total
number of domains increased not proportionally to the
amount of reads but rather approaching to a plateau
(Fig. 4b). The overall appearance of MDL plot was
notably unaffected even upon substantial reduction of
data especially under low threshold values, although too
extensive deletion of data (e.g., 90 % deletion) resulted in
an increase in domain size and subsequent right-ward
shift of the plot (Fig. 4d and Additional file 7). The result
of clustering also supported the substantial robustness of
MDL plots (Fig. 4a).
These results indicated that changepoint detection
followed by MDL plotting enables one to grasp the
trends in methylome largely independently of data size,
that is, even from rather shallow data. We thus expect
MDL plot can serve as a robust signature of each
Fig. 4 MDL plots as a signature of methylome. a Unsupervised clustering of MDL plots. WGBS data for human fibroblast IMR90 and ESC H1 [4],
ESC-derived lineages including mesendoderm, trophoblast-like cell, neural progenitor cell and mesenchymal stem cell [6], cultured mammary
epithelial cells and a low-passage breast cancer cell line [18], hematopoietic lineage cells including hematopoietic stem/progenitor cell (Hspc),
CD133-positive hematopoietic stem cell (CD133 hsc), neutrophil and B-cell [19], placenta [16] and sperm [24] were subjected to changepoint
detection followed by MDL plotting. We also included variously down-sized IMR90 data (see below). CpG sites covered by at least five reads
were used for calculation. We performed Ward’s clustering using the Spearman’s rank-order correlation coefficient (see Methods). The heatmap
illustrates the relationships across cell types based on MDL plots. The graded colors from red to white at the top left represent from similar to
dissimilar in terms of the Spearman’s rank-order correlation coefficient between samples. b Effects of data size on the number of domains. We
segmented the methylomes using the ten variously downsized IMR90 data under three different thresholds or minimal depth to select CpG sites
for calculation of methylation level (i.e., ≥3, ≥5 or ≥10 reads). c Effects of data size on genomic coverage. d Effects of data size on MDL plot of
IMR90 cells. The percentile on each plot indicates the fraction of data used for the analysis. CpG sites covered by at least three reads were used
for calculation
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methylome to facilitate comparison among WGBS data
substantially differing in their sizes.
Discussion
This work proposes an application of changepoint de-
tection to demarcate domains in the methylome based
on base-resolution data obtained by WGBS (Fig. 1).
Thanks to the efficient algorithm termed PELT [14],
human WGBS data can be analysed within 20 min with
a single thread of processor: our implementation of chan-
gepoint detection was competitive enough or even su-
perior to other approaches for methylome segmentation
(Additional file 8). Another advantage of this method
would be its simplicity in optimization, since it requires
only a single parameter termed “penalty” to be tuned for
sensitivity control (Fig. 2).
Despite the lightness of calculation and the simplicity
in parameter optimization, changepoint detection can
well segment the methylome in a largely comparable
manner with previous approaches, detecting both ubi-
quitous and cell type-specific methylated domains
(Fig. 3). Of note, even a single penalty value of 1.0 can
substantially, albeit not optimally, cover various methy-
lome characteristics, each of which was originally de-
fined using a distinct set of optimized parameters. While
the penalty value of 1.0 is a good point to start with, we
also recommend users to increase or decrease the pen-
alty value depending on the size and CpG-density of the
domains on which they intend to put emphasis (see
below).
Changepoint detection uses every CpG dinucleotide
for calculation to fully exploit the base-resolution. This
is an obvious advantage of changepoint detection over
window-based approach, because the former has much
higher spatial resolution than the latter, resolution of
which is inevitably limited by the sizes of window and
step. Accordingly, the former often provides intuitively
more natural boundaries than the latter (Additional file 5).
Furthermore, changepoint detection can cover changes of
any size, in sharp contrast with window-based approach,
which is insensitive to changes whose sizes are smaller
than the window size. It can thus simultaneously detect
such changes that occur even in contrasting size ranges,
including global hypermethylation and focal hypomethyla-
tion in cancer methylomes (Fig. 3e). On the other hand,
changepoint detection tends to induce over-segmentation
of large features including PMDs and DMVs, both of
which were originally defined by window-based ap-
proaches. Although it remains elusive and/or depends on
the purpose of studies whether or not one should stick to
the original definitions, one can simply use higher penalty
values to obtain results largely comparable to those in the
original studies (Additional file 4).
HMM-based segmentation represents another useful
approach that fully exploits the base-resolution of
WGBS data [5]. However, to use this approach, one has
to determine the number of states as well as the process
to define a domain based on the states of CpG sites,
both of which cannot be rationally deduced and would
require substantial optimization through trials and er-
rors. By contrast, changepoint detection requests its
users to tune only the penalty value but not any criteria
for subsequent domain definition. Intriguingly, these two
approaches share a problem of PMD over-segmentation.
To overcome this issue, MethylSeekR included an
HMM-based masking of PMDs prior to identification of
LMRs and UMRs [15]. While a similar two-step ap-
proach may be plausible for changepoint detection, the
effect of over-segmentation can be readily mitigated by
simply increasing the penalty value (Additional file 4).
We thus note that changepoint detection can be flexibly
adapted to various modifications, since it has only a sin-
gle parameter to be tuned.
Changepoint detection would be also useful for the de-
tection of DMRs. As shown in Fig. 1b, comparison of
calculated domains between two methylome data readily
led to the identification of previously described DMRs:
DMR can be identified either as a domain sharing the
same boundaries but with different methylation levels
between the two data or as any shift of boundaries.
Another limitation of changepoint detection that we
are currently aware of is that it cannot detect a region
with a gradually increasing or decreasing methylation
level, since the algorithm is based on a model postulat-
ing that a domain is consist of data points with a single
mean value with a single dispersion. In principle, a slope
in methylation level should be a reflection of underlying
cellular heterogeneity or cell-to-cell variation of domain
border, presumably caused by a tug-of-war between
methylating and demethylating activities. To correctly
detect such biologically interesting regions, the method
has to employ a different model for domain definition.
Once a methylome is segmented into distinct domains,
their overall composition or their number, sizes and
methylation levels can serve as a signature of the methy-
lome. To grasp the domain composition intuitively, we
devised a representation termed MDL that plots the size
and methylation level on the X- and Y-axes, respectively.
This simple plot reveals three basic clusters of domains,
which largely correspond to the FMRs, LMRs and UMRs
defined using an HMM approach (Fig. 3 and Additional
file 3). The MDL plot is also useful to examine PMDs
(Additional file 4). The presence of PMDs has been indi-
cated in the literature by either browser screenshots of
typical PMDs or a scatter plot wherein X- and Y-
coordinates of each dot indicate methylation levels of a
window in the two samples to be compared [21]. While
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this plot is useful to compare two methylomes and can
indicate the presence of hypomethylated windows, it
cannot tell whether or not such windows are continuous
or clustered in the genome to constitute PMDs. By con-
trast, MDL plot explicitly indicates the presence of
PMDs as well as their global status, since it displays both
the methylation levels and the sizes of each methylated
domain. In addition, MDL plot displays domain sizes in
a logarithmic scale, it can cover a wide range of domain
size. Consequently, comparison of MDL plots between
normal mammary epithelial cells and breast cancer cells
highlighted the emergence of small hypermethylated do-
mains and large hypomethylated domains in the latter
(Fig. 3e).
Intriguingly, the MDL plots of related cell types were
often placed in close vicinity on the clustering dendro-
grams (Fig. 4a). These results may indicate an intriguing
possibility of cell lineage-dependent strategy in methy-
lome segmentation, prevalence, underlying mechanisms
and biological significance of which remain to be seen in
the future studies using a more sophisticated method to
evaluate the similarity between MDL plots. In this con-
text, it would be also important to compare methylomes
between different species, and MDL plots are readily
applicable to such interspecies comparison. For instance,
it is obvious from MDL plots that both human and
mouse placenta have prominent PMDs. We thus expect
that MDL can be a versatile tool for comparative
epigenomics.
Furthermore, MDL plot was largely unaffected by
the size of WGBS data, retaining its pattern even when
the data were substantially deleted (Fig. 4a and d and
Additional file 7). As it can extract the global trends of
methylome even from rather shallow WGBS data, it
would enable direct comparison among WGBS data of
various sizes to facilitate their integration.
While we applied changepoint detection to base-
resolution methylome data in this study, we also noticed
that changepoint detection is useful for analysing ChIP-
Seq data to detect peaks of various histone modifica-
tions, in particular, broad peaks for suppressive chroma-
tin marks such as trimethylation at the 9th and 27th
lysine residues of histone H3 (unpublished observation).
Consistently, a similar attempt was recently reported to
analyse ChIP-chip data for histone modifications [22].
Conclusions
Changepoint detection provides a useful method to
define methylated domains based on base-resolution
methylome data. Global visualization of the domains thus
defined on MDL plot reveals a robust signature of each
methylome, facilitating comparison of various methy-
lome data.
Methods
WGBS data and their mapping
All sequence data used in this study were downloaded
from DDBJ Sequence Read Archive and did not include
any controlled-access data. Accordingly, this study did
not require any ethics approval. WGBS reads were
mapped to UCSC human genome 19 (hg19) or mouse
genome 9 (mm9), as described previously [23]. However,
we used hg18 in comparative analyses on PMDs and
DMVs (Additional files 4 and 5), because the original
studies on these features were based on hg18 [4, 6].
Changepoint detection and methylated domain
landscape plotting
We processed and visualized the mapped reads using an
in-house pipeline. We calculated domains using the R
package “changepoint” [14] and an implementation of
our own named SimpleChangepointCalculator for the
data shown in Fig. 1 and those in Figs. 2, 3 and 4, respec-
tively. Identified domains were visualized using functions
of either R or SimpleChangepointCalculator. Simple-
ChangepointCalculater is available at http://itolab.med.
kyushu-u.ac.jp/CPT/.
Unsupervised clustering of MDL plots
Each MDL plot was divided into 400 (= 20 × 20) pixels.
MDLs were then subjected to Ward’s clustering using
Spearman’s rank-order correlation coefficient calculated
from the number of domains in each pixel.
Additional files
Additional file 1: MDL plots for eight publically available WGBS
data. (PDF 471 kb)
Additional file 2: MDL plots for WGBS data on 17 mouse adult
tissues. (PDF 850 kb)
Additional file 3: Comparison between HMM-defined methylated
regions and clusters of changepoint-defined domains. (PDF 278 kb)
Additional file 4: Comparison of PMDs detected by window-based
and changepoint detection approaches. (PDF 551 kb)
Additional file 5: Comparison of DMVs detected by window-based
and changepoint detection approaches. (PDF 422 kb)
Additional file 6: Unsupervised clustering of MDL plots.
(PDF 261 kb)
Additional file 7: Effects of data size on MDL plots. (PDF 324 kb)
Additional file 8: Performance comparison among methylome
segmentation tools. (PDF 192 kb)
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